GUOQUAN (02517) announced that its shareholders are expected to approve a general mandate at the 2025 annual general meeting. This mandate would authorize the board of directors to repurchase the company's H-shares, up to a maximum of 10% of the total issued H-shares at the time the resolution is passed. The repurchase mandate will expire on the earliest of the following dates: the conclusion of the company's 2026 annual general meeting, or the date the mandate is revoked or amended by a special resolution of the shareholders.

On April 22, 2026, the board resolved that, subject to the approval of the repurchase mandate by shareholders, it intends to utilize up to HKD 200 million of its own funds to conduct a further H-share buyback on the open market. This buyback program would be active from the date the mandate is approved until its expiry. The actual price paid for each H-share repurchased shall not exceed a premium of 5% or more above the average closing price of the H-shares in the five trading days immediately preceding each repurchase. H-shares bought back under this mandate may be either cancelled or held as treasury shares.

The board believes that the current share trading price does not fully reflect the company's intrinsic value and business prospects. It considers that a share repurchase under the present circumstances demonstrates the confidence of the company and its management team in the business development outlook and growth potential, which will ultimately benefit the company and create value for shareholders.